Published by Josh White on 20th June 2025
(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth up to £16m plus royalties.
URL: http://www.digitallook.com/dl/news/story/35164893/...